JANX
NASDAQ · Biotechnology
Janux Therapeutics Inc
$14.18
-0.37 (-2.51%)
Open$14.44
Previous Close$14.54
Day High$14.65
Day Low$13.88
52W High$35.34
52W Low$12.12
Volume—
Avg Volume865.5K
Market Cap884.49M
P/E Ratio—
EPS$-1.83
SectorBiotechnology
Analyst Ratings
Strong Buy
26 analysts
Price Target
+246.4% upside
Current
$14.18
$14.18
Target
$49.10
$49.10
$33.46
$49.10 avg
$61.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.98M | 9.50M | 135.69M |
| Net Income | -113,412,942 | -97,100,121 | 14.63M |
| Profit Margin | -1,136.3% | -1,079.4% | 10.8% |
| EBITDA | -155,349,011 | -140,393,417 | 20.57M |
| Free Cash Flow | — | — | 20.68M |
| Rev Growth | +5.1% | +5.1% | +1.9% |
| Debt/Equity | — | — | 0.42 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |